Document is current

Article History

Received: 28 August 2023

Accepted: 19 October 2023

First Online: 3 November 2023

Declarations

:

: The study protocol was approved by the institutional review board of King Hussein Cancer Center (KHCC), with a waiver of consent due to the retrospective nature of the study (IRB number 20KHCC134 /Aug 19, 2020).

: Not applicable.

: The authors have no relevant financial or non-financial interests to disclose.